Article info
PDFStudent essay
Ethics of placebo use in clinical practice: why we need to look beyond deontology
- Correspondence to Sally Spurr, Medicine, University of London St George's, London SW17 0RE, UK; m1700928{at}sgul.ac.uk
Citation
Ethics of placebo use in clinical practice: why we need to look beyond deontology
Publication history
- Received March 30, 2020
- Revised July 25, 2020
- Accepted July 30, 2020
- First published September 10, 2020.
Online issue publication
April 13, 2021
Article Versions
- Previous version (13 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Placebo treatments, informed consent and ‘the grip of a false picture’
- Parsing placebo treatments: a response to Barnhill and Miller
- Are ethical principles relative to time and place? A Star Wars perspective on the Alder Hey affair
- Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
- The ethics of placebo treatments in clinical practice: a reply to Glackin
- and the profession of medicine
- More than consent for ethical open-label placebo research
- Physician perspectives on placebo ethics
- Intuitions, principles and consequences
- Replication crisis and placebo studies: rebooting the bioethical debate